Granted Patent
B2
US 9,102,653 · App. 14/322,165 · Granted Aug 11, 2015
Substituted quinazolinones as vanilloid antagonists
Inventors:
Timothy John Ritchie (Horsham, GB); Andrew James Culshaw (Horsham, GB); Christopher Thomas Brain (Horsham, GB); Edward Karol Dziadulewicz (Horsham, GB); Terance William Hart (High Peak, GB)
Assignee:
NOVARTIS AG
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present specification relates to the use of a quinazolinone compound of the formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form.
Claims (3)
1. A method for treating eye pain in a mammal, comprising:
administering to a mammal in need thereof a therapeutically effective amount of a quinazolinone compound of the formula:
in free base form or in pharmaceutically acceptable acid addition salt form.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 6, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065790/0208 →
Priority Claims (1)
GB 0412769.2
· Jun 8, 2004
· national
Continuity (4)
Continuation
11569802